Financials
- Market Capitalization 392.49 M
- Employee 350
- Founded 2012
- CEO David Moatazedi
- Website www.evolus.com
- Headquarter Delaware, United States
- FIGI BBG005CX4HK8
- Industry Fabricants de Médicaments — Spécialités et Génériques
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-6.23
ratio cours/chiffre d'affaires
0.88
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2932 | AQST Aquestive Therapeutics, Inc. - Common Stock | 3.96 USD | -1.98% | -6.60% | -5.71% | -2.46% | 496.78 M USD | ||
| 3068 | KMDA Kamada Ltd. - Ordinary Shares | 7.18 USD | -1.24% | -0.83% | -3.10% | -5.40% | 414.19 M USD | ||
| 3085 | CGC Canopy Growth Corporation - Common Shares | 0.96 USD | 0.00% | +1.05% | -3.03% | -13.51% | 405.27 M USD | ||
| 3123 | EBS Emergent BioSolutions Inc. Common Stock | 7.83 USD | +4.26% | -4.40% | -5.66% | -26.96% | 404.00 M USD |